Long-Term Liabilities: The sum of all non-current liabilities.
Arcturus Therapeutics Holdings Inc. (ARCT) had Long-Term Liabilities of $20.78M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$82.03M |
|
$-65.78M |
|
-- |
|
$82.03M |
|
$158.29M |
|
$-76.26M |
|
$10.48M |
|
$-65.78M |
|
$-65.78M |
|
$-65.78M |
|
$-65.78M |
|
$-65.78M |
|
$-65.78M |
|
$-76.26M |
|
$-73.23M |
|
27.39M |
|
27.39M |
|
$-2.40 |
|
$-2.40 |
|
| Balance Sheet Financials | |
$241.45M |
|
$6.74M |
|
$29.70M |
|
$271.15M |
|
$36.38M |
|
-- |
|
|
Long-Term Liabilities |
$20.78M |
$57.16M |
|
$213.99M |
|
$213.99M |
|
$213.99M |
|
28.41M |
|
| Cash Flow Statement Financials | |
$-74.27M |
|
$-0.23M |
|
$13.38M |
|
$293.91M |
|
$232.79M |
|
$-61.12M |
|
$25.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-92.96% |
|
-92.96% |
|
-89.28% |
|
-80.19% |
|
-80.19% |
|
$-74.50M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
-- |
|
14.74 |
|
24.76 |
|
-30.74% |
|
-30.74% |
|
-24.26% |
|
-30.74% |
|
$7.53 |
|
$-2.72 |
|
$-2.71 |
|